AlloWrap DS is an allogenic matrix.
INTENDED USES: Designed to provide a biologic barrier following surgical repair.
CLAIMED FEATURES: The double-sided membrane features two layers of amniotic tissue orientated with the epithelial layers facing outwards, eliminating application orientation restrictions. Immune privileged. Tissue remains in surgical site greater than eight weeks. Double-sided epithelial layer allows for maximum tissue barrier opportunities as an onlay and/or in wrapping tissue applications. Two-year shelf life. Room temperature storage.
OPTIONS: per square centimeter
The addition of Skin Substitutes or Cellular or Tissue Based Products (CTPs) to certain wounds may afford a healing advantage over dressings and conservative treatments when these options appear insufficient to affect complete healing, after at least a 30 day period of comprehensive conservative therapy. There are currently a wide variety of bioengineered products available for soft tissue coverage to affect closure. • Human skin allografts are derived from donated human skin (cadavers) • Allogeneic matrices are derived from human tissue (fibroblasts or membrane) • Composite matrices are derived from human keratinocytes, fibroblasts and xenogeneic collagen • Acellular matrices are derived from xenogeneic collagen or tissue
For Medicare to cover this product, it needs to be ordered and applied by your clinician. A patient cannot purchase it directly from a Durable Medical Equipment (DME) store and receive reimbursement for it.
An invitation to view this topic will be emailed to specified recipients.
Sorry, this content is only available to registered members. Please register for FREE account to gain access.
To access this premium feature and more, upgrade to a premium plan today. Or browse to enjoy free content and tools.
WoundReference is a clinical decision support platform for experienced and new wound care clinicians at the point-of-care